Literature DB >> 303242

Urogastrone levels in the urine of normal adult humans.

H Gregory, J E Holmes, I R Willshire.   

Abstract

Urogastrone is a potent inhibitor of gastric acid secretion isolated from human urine and it is structurally related to and shares the properties of a potent mitogen-mouse epidermal growth factor. The amounts of urogastrone in 24 h normal human urine samples were measured using a specific and sensitive radioimmunoassay. Values varied from 120--1360 ng/kg/24 h but a significant difference (2P less than 0.005) was observed between urine samples from men (602 +/- 41 SE, n = 39) and women (782 +/- 44 SE, n = 33). A series of 24 h urine collections from male and female volunteers showed that wide variations could occur over a 4 week period in the individual output of urogastrone. Levels from women did not show variations that could be related to the stage of the menstrual cycle.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 303242     DOI: 10.1210/jcem-45-4-668

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  11 in total

1.  Immunohistochemical localisation of urogastrone to human duodenal and submandibular glands.

Authors:  P U Heitz; M Kasper; S van Noorden; J M Polak; H Gregory; A G Pearse
Journal:  Gut       Date:  1978-05       Impact factor: 23.059

2.  Intravenous but not intragastric urogastrone-EGF is trophic to the intestine of parenterally fed rats.

Authors:  R A Goodlad; T J Wilson; W Lenton; H Gregory; K G McCullagh; N A Wright
Journal:  Gut       Date:  1987-05       Impact factor: 23.059

3.  Reduced epidermal growth factor receptor expression in hypohidrotic ectodermal dysplasia and Tabby mice.

Authors:  G A Vargas; E Fantino; C George-Nascimento; J J Gargus; H T Haigler
Journal:  J Clin Invest       Date:  1996-06-01       Impact factor: 14.808

4.  Expression in Bacillus subtilis of the gene for human urogastrone using synthetic ribosome binding sites.

Authors:  J I Flock; I Fotheringham; J Light; L Bell; R Derbyshire
Journal:  Mol Gen Genet       Date:  1984

5.  Human plasma epidermal growth factor/beta-urogastrone is associated with blood platelets.

Authors:  Y Oka; D N Orth
Journal:  J Clin Invest       Date:  1983-07       Impact factor: 14.808

6.  Chronic cystitis: excretion of epidermal growth factor (EGF)/urogastrone (URO).

Authors:  M Holm-Bentzen; G Lose; K Sørensen; L Jørgensen; E Nexø
Journal:  Urol Res       Date:  1987

7.  Prospective evaluation of candidate urine and cell markers in patients with interstitial cystitis enrolled in a randomized clinical trial of Bacillus Calmette Guerin (BCG).

Authors:  Susan Keay; Jay E Reeder; Kristopher Koch; Chen-Ou Zhang; Daivd Grkovic; Kenneth Peters; Yawei Zhang; John W Kusek; Lee M Nyberg; Christopher K Payne; Kathleen J Propert
Journal:  World J Urol       Date:  2007-08-13       Impact factor: 4.226

8.  Immunoreactive low-molecular-weight epidermal growth factor in urine of patients with renal cell carcinoma.

Authors:  P le Coutre; S Bock; G Jakse; P E Petrides
Journal:  Urol Res       Date:  1992

9.  Urinary epidermal growth factor (hEGF) levels in patients with carcinomas of the breast, colon and rectum.

Authors:  J W Sweetenham; D E Davies; S Warnes; P Alexander
Journal:  Br J Cancer       Date:  1990-09       Impact factor: 7.640

10.  Intraluminal epidermal growth factor affects growth of N-methyl-N-nitrosourea-initiated rat bladder carcinoma.

Authors:  K Kawai; H Kawamata; S Kameyama; A Rademaker; R Oyasu
Journal:  Jpn J Cancer Res       Date:  1995-05
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.